JARID2 Antikörper
-
- Target Alle JARID2 Antikörper anzeigen
- JARID2 (Jumonji, AT Rich Interactive Domain 2 (JARID2))
-
Reaktivität
- Human, Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser JARID2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human JARID2
- Isotyp
- IgG
- Top Product
- Discover our top product JARID2 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500 - 1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1 mg/mL
- Buffer
- Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- JARID2 (Jumonji, AT Rich Interactive Domain 2 (JARID2))
- Andere Bezeichnung
- JARID2 (JARID2 Produkte)
- Hintergrund
-
Synonyms: JARD2,JARD2,JARID2,JMJ,Jumonji AT rich interactive domain 2 ,Jumonji homolog,Jumonji like protein,Jumonji protein,Jumonji/ARID domain containing protein 2,Jumonji/ARID domain-containing protein 2,Protein Jumonji
Background: This gene encodes a Jumonji- and AT-rich interaction domain (ARID)-domain-containing protein. The encoded protein is a DNA-binding protein that functions as a transcriptional repressor. This protein interacts with the Polycomb repressive complex 2 (PRC2) which plays an essential role in regulating gene expression during embryonic development. This protein facilitates the recruitment of the PRC2 complex to target genes. Alternate splicing results in multiple transcript variants. Mutations in this gene are associated with chronic myeloid malignancies.
- Molekulargewicht
-
Observed_MW: 139kDa
Calculated_MW: 106kDa/119kDa/138kDa
- Gen-ID
- 3720
- UniProt
- Q92833
- Pathways
- Chromatin Binding
-